Composition for protection against superficial vasodilator flush syndrome

a vasodilator and flush syndrome technology, applied in the field of inflammatory conditions, can solve the problems of less than 5% of the chondroitin sulfate in commercially available preparations being absorbed orally, and the possibility of contracting spongiform encephalopathy or “mad cow disease”

Inactive Publication Date: 2005-10-06
THEOHARIDES THEOHARIS C
View PDF3 Cites 38 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0023] The inventive olive kernel extract may be used to increase the absorpti...

Problems solved by technology

However, less than 5% of the chondroitin sulfate in commercially available preparations is absorbed orally, because the size of the molecule and the degree of sulfation impede its absorption from th...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0040] Table 1 compares chondroitin sulfate-containing commercial products to the present compositions.

TABLE 1Comparison of Chondroitin Sulfate-Containing Productsto Present InventionMost AvailableProductCompositionsPresent InventionMain ingredientMixture ofNon-bovine chondroitinchondroitinssulfate, preferably the CtypeSourceCow tracheaShark cartilageAmount per100-30010-3000 mgcapsule or tabletDegree of sulfationLow, if anyHighAbsorption from g.i.>15%tractTargetUnknownMast cells, inflammatorycellsOther ingredientsVitamins, fish oilsFlavones, unrefined(some preparations)kernel olive oil, SAM,histamine-1 receptorantagonists, histamine-3receptor agonists, CRHantagonists, polyamines,caffeine, folic acidAdvantagesNone knownAnti-allergic, anti-inflammatory, anti-oxidant, cytoprotectiveAdverse effectsRisk of mad cowNone knowndisease, spongiformencephalopathy,stomach upset, allergyto fish productsRelevant conditionsOsteoarthritisAllergic inflammationangina, asthma coronaryartery disease, ...

example 2

Composition For Protecting Against Inflammatory Diseases

[0042] Two capsules to be taken orally 2-3 times daily, at least one hour before meals

Ingredients, per capsule.mg:Chondroitin sulfate150-300D-Glucosamine sulfate150-300Quercetin150-300Olive kernel extract350-1200

example 3

Composition For Protecting Against Arthritis

[0043]

Ingredients per capsule,mg:D-Glucosamine sulfate150-300Chondroitin sulfate150-300Sodium hyaluronate100-200Quercetin150-300Olive kernel extract350-1200

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Weightaaaaaaaaaa
Weightaaaaaaaaaa
Weightaaaaaaaaaa
Login to view more

Abstract

Compositions with synergistic anti-inflammatory effects in inflammatory diseases resulting from activation and consequent degranulation of mast cells and followed by secretion of inflammatory biomolecules from the activated mast cells, composed of a heavily sulfated, non-bovine proteoglycan such as shark cartilage chondroitin sulfate C, an unrefined olive kernel oil/extract that increases absorption of these compositions in various routes of administration, and one or more of a hexosamine sulfate such as D-glucosamine sulfate, a flavone such as quercetin, S-adenosylmethionine, a histamine-1 receptor antagonist, a histamine-3 receptor agonist, an antagonist of the actions of CRH, caffeine, and a polyamine.

Description

BACKGROUND OF THE INVENTION [0001] The invention is generally related to the treatment of inflammatory conditions. More specifically, the invention is related to compositions containing inhibitors of mast cell activation and secretion such as a proteoglycan that are designed to be used as dietary supplements or adjuvants to conventional approved medications for the relief of inflammatory conditions. [0002] There have been a number of mostly anecdotal reports that the proteoglycan chondroitin sulfate, as well as glucosamine sulfate, a product of the intestinal breakdown of proteoglycans, may be helpful in relieving the pain of osteoarthritis:—Shute N. Aching for an arthritis cure. US News and World Report, Feb. 10, 1997.— Cowley G. The arthritis cure? Newsweek, Feb. 17, 1997; Foreman J., People, and their pets, tout arthritis remedy. The Boston Globe, Apr. 7, 1997; Tye L. Treatment gains scientific attention. The Boston Globe, Sep. 25, 2000. [0003] A recent meta-analysis showed poten...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/737A61K31/7008A61K31/522A61Q17/04A61K36/63A61K8/73A61K8/60A61K8/97A61K8/49A61Q11/00
CPCA61K8/498A61K8/60A61K8/735A61K8/97A61K31/353A61K31/473A61K31/4965A61K31/522A61K31/55A61K31/7008A61K31/737A61K36/63A61K36/76A61Q11/00A61Q17/04A61K2300/00A61K8/9789
Inventor THEOHARIDES, THEOHARIS C.
Owner THEOHARIDES THEOHARIS C
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap